Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

IL-25 attenuates rheumatoid arthritis through suppression of Th17 immune responses in an IL-13-dependent manner.

Liu D, Cao T, Wang N, Liu C, Ma N, Tu R, Min X.

Sci Rep. 2016 Nov 4;6:36002. doi: 10.1038/srep36002.

2.

A novel inhibitor of p75-neurotrophin receptor improves functional outcomes in two models of traumatic brain injury.

Delbary-Gossart S, Lee S, Baroni M, Lamarche I, Arnone M, Canolle B, Lin A, Sacramento J, Salegio EA, Castel MN, Delesque-Touchard N, Alam A, Laboudie P, Ferzaz B, Savi P, Herbert JM, Manley GT, Ferguson AR, Bresnahan JC, Bono F, Beattie MS.

Brain. 2016 Jun;139(Pt 6):1762-82. doi: 10.1093/brain/aww074.

3.

Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.

Goodall LJ, Ovecka M, Rycroft D, Friel SL, Sanderson A, Mistry P, Davies ML, Stoop AA.

PLoS One. 2015 Sep 9;10(9):e0137065. doi: 10.1371/journal.pone.0137065.

4.
5.

Regulation of inflammation-associated olfactory neuronal death and regeneration by the type II tumor necrosis factor receptor.

Pozharskaya T, Liang J, Lane AP.

Int Forum Allergy Rhinol. 2013 Sep;3(9):740-7. doi: 10.1002/alr.21187.

6.

Cysteine-rich domain 1 of CD40 mediates receptor self-assembly.

Smulski CR, Beyrath J, Decossas M, Chekkat N, Wolff P, Estieu-Gionnet K, Guichard G, Speiser D, Schneider P, Fournel S.

J Biol Chem. 2013 Apr 12;288(15):10914-22. doi: 10.1074/jbc.M112.427583.

7.

Enhanced COMP catabolism detected in serum of patients with arthritis and animal disease models through a novel capture ELISA.

Lai Y, Yu XP, Zhang Y, Tian Q, Song H, Mucignat MT, Perris R, Samuels J, Krasnokutsky S, Attur M, Greenberg JD, Abramson SB, Di Cesare PE, Liu CJ.

Osteoarthritis Cartilage. 2012 Aug;20(8):854-62. doi: 10.1016/j.joca.2012.05.003.

8.

Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis.

Merrill JC, You J, Constable C, Leeman SE, Amar S.

Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21247-52. doi: 10.1073/pnas.1111492108.

9.

Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.

Shoda H, Fujio K, Shibuya M, Okamura T, Sumitomo S, Okamoto A, Sawada T, Yamamoto K.

Arthritis Res Ther. 2011;13(6):R191. doi: 10.1186/ar3520.

10.

Progranulin: a promising therapeutic target for rheumatoid arthritis.

Liu CJ.

FEBS Lett. 2011 Dec 1;585(23):3675-80. doi: 10.1016/j.febslet.2011.04.065. Review.

11.

Medicine. Progranulin resolves inflammation.

Wu H, Siegel RM.

Science. 2011 Apr 22;332(6028):427-8. doi: 10.1126/science.1205992. No abstract available.

12.

The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice.

Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, Su J, Yin F, Ding AH, Zanin-Zhorov A, Dustin ML, Tao J, Craft J, Yin Z, Feng JQ, Abramson SB, Yu XP, Liu CJ.

Science. 2011 Apr 22;332(6028):478-84. doi: 10.1126/science.1199214.

13.

Targeted tumor necrosis factor receptor I preligand assembly domain improves skin lesions in MRL/lpr mice.

Deng GM, Liu L, Tsokos GC.

Arthritis Rheum. 2010 Aug;62(8):2424-31. doi: 10.1002/art.27534.

14.

Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway.

Deng GM, Liu L, Kyttaris VC, Tsokos GC.

J Immunol. 2010 Jun 15;184(12):7154-61. doi: 10.4049/jimmunol.0902514.

15.

c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.

Paniagua RT, Chang A, Mariano MM, Stein EA, Wang Q, Lindstrom TM, Sharpe O, Roscow C, Ho PP, Lee DM, Robinson WH.

Arthritis Res Ther. 2010;12(1):R32. doi: 10.1186/ar2940.

16.

Autoimmunity against fibrinogen mediates inflammatory arthritis in mice.

Ho PP, Lee LY, Zhao X, Tomooka BH, Paniagua RT, Sharpe O, BenBarak MJ, Chandra PE, Hueber W, Steinman L, Robinson WH.

J Immunol. 2010 Jan 1;184(1):379-90. doi: 10.4049/jimmunol.0901639.

17.

Structure and signalling in the IL-17 receptor family.

Gaffen SL.

Nat Rev Immunol. 2009 Aug;9(8):556-67. doi: 10.1038/nri2586. Review. Erratum in: Nat Rev Immunol. 2009 Oct;9(10):747.

18.

Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.

Ramaswamy M, Cleland SY, Cruz AC, Siegel RM.

Results Probl Cell Differ. 2009;49:17-47. doi: 10.1007/400_2008_24. Review.

19.

TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Li H, Luo K, Pauza CD.

J Immunol. 2008 Nov 15;181(10):7131-7.

20.

Human genetic approaches to diseases of lymphocyte activation.

Prabhakar M, Lenardo MJ.

Immunol Res. 2009;43(1-3):8-14. doi: 10.1007/s12026-008-8045-x.

Supplemental Content

Support Center